Sustained virologic response after therapy with the HCV protease inhibitor narlaprevir in combination with peginterferon and ribavirin is durable through long-term follow-up

Daphne Hotho, Joep Bruijne, Michelle Spaan, MA Treitel, Andre Boonstra, Rob de Knegt, HLA Janssen, HW Reesink

Research output: Contribution to journalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)e78-e81
JournalJournal of Viral Hepatitis
Volume20
Issue number4
DOIs
Publication statusPublished - 2013

Research programs

  • EMC MM-04-20-01
  • EMC MM-04-20-02-A

Cite this